Clinical trial

A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated…

NCT00203814 · University of Cape Town, Other · Completed

Key facts

NCT number NCT00203814
Title A Randomised Efficacy Study of Combination Antimalarials to Treat Uncomplicated Malaria
Official title Open-Label, Randomised, Parallel Group in Vivo Drug Study to Evaluate Combination Anti-Malarial Therapy (CAT), Artesunate and Sulfadoxine-Pyrimethamine Versus Sulfadoxine-Pyrimethamine Alone, in Terms of Therapeutic Efficacy, Prevalence of Gametocyte Carriage and Prevalence of Molecular Markers…
Lead sponsor University of Cape Town, Other
Collaborators World Health Organization Medical Research Council, South Africa
Status Completed
Study type Interventional
Conditions Malaria
Intervention type Drug
Interventions Sulfadoxine-pyrimethamine, Artesunate plus sulfadoxine-pyrimethamine
Enrollment 280
Start date Jan 1, 2004
Completion Mar 1, 2005
First posted Sep 20, 2005
Last update posted Nov 16, 2006
Countries Mozambique

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies